Conference Call In no order of importance, here are my concerns I'd like to see McRae address on the Jan. 10 call:
Cash burn - no specific question here. I'm sure once the topic gets started, it will get thoroughly explored
NOC/c filing for Urocidin - where is BNC in the process?
Is BNC looking to do another type of financing this year? This question, in one form or another should be asked as direct as possible.
Will McRae be stepping down/retiring/leaving to let someone else steer the ship?
VMC status for Good Manufacturing Practice approval - on schedule? Give us a date.
Econiche - the snoozefest continues for the foreseeable future?
(look at page 2 of the Fiscal 2012 Annual Report to see Objectives, Activites and Status - McRae should be prepared to address these issues)